Wolfgang Miesbach/LinkedIn,Sophie Susen/MHEMO
May 5, 2026, 11:35
Wolfgang Miesbach: How Should We Approach GI Angiodysplasia in VWD?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”How should we approach GI angiodysplasia in VWD?
This was the topic of an excellent talk by Sophie Susen at the EHA scientific meeting in Florence, highlighting how complex and under‑recognized this problem still is in VWD:
Diagnosis – stepwise
- Start with gastroscopy plus colonoscopy in all patients with overt GI bleeding or otherwise unexplained iron‑deficiency anemia.
- If negative, move to video capsule endoscopy; use deep enteroscopy for targeted therapy of detected small‑bowel angiodysplasia.
Treatment – pragmatic algorithm
- Acute bleed: stabilize, give iron ± transfusion, VWF/FVIII and TXA in VWD, plus endoscopic hemostasis whenever feasible.
- Recurrent bleeding: optimize VWF prophylaxis, accepting that its effect on angiodysplasia is often limited.
- Transfusion‑dependent / refractory cases: add systemic therapy – somatostatin analogues (e.g. octreotide) as first‑line; consider off‑label anti‑angiogenics (thalidomide, lenalidomide, bevacizumab) in carefully selected patients.
- Focal, resistant lesions: discuss angiographic embolization or surgery in a multidisciplinary board.
A structured algorithm that combines modern small‑bowel imaging, tailored VWF management and stepwise systemic therapy is key to reducing rebleeding, transfusions and hospitalizations in VWD patients with angiodysplasia.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice